Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4455_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
47 Мб
Скачать
212 Disorders of the Auditory System
https://t.me/medicina_free
and speech recognition scores often fluc­tuate in patients with active Ménière’s disease.
Videonystagmography may further be used to confirm clinical findings of vestibulopathy; however, this test is nor­mal in many patients with Ménière’s disease, particularly in the early stages of the disease. Electrocochleography is a test that measures evoked potentials from the cochlea and the cochlear nerve, which has been used to assist in the diagnosis of Ménière’s disease. Summating poten­tials (SP) and action potentials (AP) are recorded and a SP/AP amplitude ratio above 0.40 is associated with endolym­phatic hydrops (Schwaber, Hall, & Zea­lear, 1991). However, one should carefully interpret test results as abnormal electro­cochleography results have been found in patients with other auditory disorders. If asymmetry in pure-tone audiometry, tuning fork evaluation, or word recogni­tion testing is identified, then radiologic testing, such as MRI, or tests such as ABR should be performed to rule out retroco­chlear pathology.
Medical Examination
The diagnosis of Ménière’s disease is made primarily by a thorough medical history and not necessarily by an exam or diag­nostic test. Specific questions should be asked to rule out other potential diagno­ses, such as perilymph fistula, ototoxicity, autoimmune disease, infectious etiologies, vestibular migraine, and retrocochlear pathology. A thorough head and neck examination augments the medical his­tory and is typically unremarkable. In the midst of a vestibular attack, patients will exhibit spontaneous nystagmus. Neuroto­logic examination of vestibular function
may indicate the side of vestibulopathy (see Clemmens & Ruckenstein, 2012).
Audiologic Management
Management of patients with Ménière’s disease is often difficult from both a medical and an audiologic standpoint. This is because the fluctuations in the disease process make it hard to predict audiologic sensitivity and speech recogni­tion ability from day to day. In addition, although many patients’ hearing sensitiv­ity warrants amplification, their speech recognition abilities are often so poor that they may receive little to no benefit from amplification. Moreover, most patients with Ménière’s disease are typically not candidates for cochlear implants because their noninvolved ear does not meet can­didacy criteria. So, for many patients with this inner ear disorder, the amplification options are often limited and those that are available may not provide optimal benefits. This is typically a function of poor word recognition ability. In cases in which bilateral involvement is significant, cochlear implantation may be considered. As outlined by Valente and colleagues, it is recommended that for those patients with serviceable hearing, that hearing aids with digital processing be employed along with directional microphones and assistive listening devices to aid in hear­ing in the presence of noise (Valente, Mispagel, Valente, & Hullar, 2006). Most patients with Ménière’s disease who are to be fit with amplification will be man­aged most effectively with programmable hearing aid devices that allow them the flexibility to have multiple programs that can accommodate their changing auditory needs. And finally, counseling regarding the use of such programs and the estab-
5. Inner Ear Disorders 213
https://t.me/medicina_free
lishment of reasonable expectations of hearing aid benefit in various listening conditions is also a critical component of any hearing aid fitting, but it is especially important when fitting a patient with Ménière’s disease for reasons alluded to previously (e.g., fluctuating hearing loss, the potential of poor speech recognition ability, changing auditory needs).
Medical Management
Acute episodes of vertigo are treated with vestibular suppressants and antiemetics, but long-term medical treatment of this disease is directed primarily at prevent­ing vertigo attacks. The uncertainty in the etiology of this disease is reflected in the types of management that are offered to patients. No medical treatment has been proven to be effective in improving hearing or decreasing tinnitus and aural fullness in all patients; however, some patients may experience some relief in all (or at least a subset) of these symptoms with treatment. Although this disease is not fatal and does not require treatment, most patients suffering from recurrent vertigo desire intervention. Hearing loss related to Ménière’s disease is typically treated with amplification. Prior to ini­tiation of treatment, the degree of usable hearing must be taken into account. Gen­erally, patients with word recognition testing scores of greater than 30% to 50% are treated medically with hearing pres­ervation options; although all patients may be treated conservatively initially. In order to decrease the endolymphatic fluid pressure, conservative medical ther­apy involves the use of a low-sodium diet and diuretics (Bojrab, Bhansali, & Battista,
1994). It has been found that some patients who follow a low-sodium diet long term
note improvements in their symptoms (Luxford, Berliner, Lee, & Luxford, 2013). Such an approach has been shown to be successful at vertigo control in 50% to 70% of patients treated (Ruckenstein, Rutka, & Hawke, 1991). The use of steroids, either through a systemic or transtympanic route, can also relieve recurrent vertigo (Bojrab et al., 1994).
When the vertigo is not reasonably controlled by these measures, further intervention is indicated, which involves ablating vestibular function on the af­fected side. It is counterintuitive to pur­posefully destroy vestibular function in patients with vestibulopathy; however, removal of residual vestibular function in the diseased ear will allow the central ves­tibular centers to compensate for the uni­lateral involvement and prevent further vertigo. Most of the ablative options have efficacy measures that range from 70% to 95%, but they carry a risk of hearing loss. The transtympanic administration of the vestibulotoxic antibiotic, gentamicin, can be used to ablate vestibular function if functional hearing is present, and typi­cally this procedure can be performed in an office setting. This type of nonsurgical ablative procedure should be supported with periodic audiologic and vestibular monitoring.
A first-line surgical procedure in the treatment of Ménière’s vertigo is a decom­pression of the endolymphatic sac and duct and placement of a shunt into the sac that allows for egress of excess endo­lymph into the mastoid, although the effi­cacy of this procedure has been debated. This surgical procedure is performed using a transmastoid surgical approach and typically is completed as an outpa­tient procedure. The vestibular nerve can also be sectioned surgically through an intracranial retrosigmoid approach
214 Disorders of the Auditory System
https://t.me/medicina_free
and carries a high success rate of vertigo relief, but requires a craniotomy and a sig­nificant postoperative recovery period. In cases where hearing is nonfunctional, a transmastoid labyrinthectomy can be per­formed by drilling away the semicircular canals and removing of all the neuroepi­thelium from the vestibule. This proce­dure removes the remainder of hearing, but is more than 95% successful at vertigo control (Schwaber, 2007). While several destructive (i.e., vestibular nerve section) and nondestructive (i.e., endolymphatic sac surgery) surgical options are avail­able, there have been no significant dif­ferences noted in patient-reported quality of life outcome measures associated with these procedures (Ballard et al., 2019).
Case 5–5: Bilateral Ménière’s Disease
History
This 53-year-old male presented with chronic and debilitating vertigo for a year prior to his evaluation. He reportedly experienced several episodes per week lasting from a few minutes to hours. He also presented with aural fullness and “roaring” tinnitus bilaterally, and men­tioned that these symptoms were more severe in his left ear than in his right ear. Hearing was reported to be significantly decreased with daily fluctuations.
Audiology
An otoscopic check was unremarkable bilaterally. The results of a comprehensive audiologic evaluation indicated a moder­ately-severe rising to a mild sensorineural hearing loss in the left ear and a severe ris­ing to a moderately-severe sensorineural
hearing loss in the right ear with asymme­try noted between the ears (Figure Speech recognition thresholds were in good agreement with pure-tone averages and word recognition was poor in the right ear and good in the left ear.
5–5).
Medical Examination
The patient presented with an essentially normal otolaryngologic examination. Imaging results revealed no retrocochlear involvement.
Impression
Probable bilateral Ménière’s disease.
Audiologic Recommendations and Management
Binaural amplification was recommended to assist the patient with his significant hearing difficulties. The patient obtained hearing aids, which were programmed with multiple programs to help manage the fluctuations in his hearing.
Medical Recommendations and Management
The decision was made to treat the patient’s left ear due to the fact that the symptoms (hearing loss, aural fullness, and tinnitus) were more severe on this side per patient report and audiologic test results, and the patient underwent a course of prednisone and gentamicin treatments and demon­strated some improvements with this approach. The prednisone and gentami­cin treatments were employed in an effort to control the vertigo by pharmacologic intervention. A transtympanic gentamicin titration was employed to depress laby­rinthine function, resulting in relief from
5. Inner Ear Disorders 215
https://t.me/medicina_free
Figure 5–5. Pure-tone thresholds, speech audiometry, and tympanometry results for a 53-year-
old male with bilateral Ménière’s disease (Case 5–5).
216 Disorders of the Auditory System
https://t.me/medicina_free
the vestibular symptoms. A low-sodium diet was also recommended to help con­trol symptoms. In addition, vestibular rehabilitation to assist with the patient’s imbalance was recommended.
Additional Information
The patient continues to struggle with bilateral Ménière’s disease; however, he has demonstrated significant improvement in his vestibular symptoms since their onset. As one would predict, no significant changes in audiologic test results for either pure-tone thresholds or word recognition were observed following treatment.
Case 5–6: Unilateral Ménière’s Disease
History
Audiology
An otoscopic check was unremarkable bilaterally. Results of a comprehensive audiologic evaluation indicated a rela­tively flat, moderate sensorineural hearing loss in the right ear and normal peripheral hearing sensitivity for the left ear (Fig­ure
5–6A). Speech recognition thresholds were in good agreement with pure-tone averages, and word recognition scores were excellent for both ears. Both VNG (including ocular motor, positional, and caloric evaluation) and vestibular evoked myogenic potentials (VEMP) examina­tions were found to be within normal limits. Due to presence of the congenital hearing loss and normal VNG findings, determining which ear was the involved ear was difficult. Electrocochleography testing was completed using a 90 dB nHL click stimulus. Results from the ECochG demonstrated a SP/AP ratio of about 60% to 70% on the right side (Figure 5–6B).
A 27-year-old graduate student was ini­tially seen for medical evaluation of a long-standing hearing loss. At the time of her evaluation, she reported that she has had a hearing loss since birth and that her hearing loss was originally diagnosed as a mild sensorineural hearing loss. However, she additionally noted that her hearing loss had become progressively worse in recent years and that, over the last several months prior to her evaluation, she had devel­oped some episodic vertigo. She denied any tinnitus or aural fullness. She initially thought that the change in her hearing loss and the origin of her episodic vertigo were caused by a mild carbon dioxide exposure, but these symptoms continued to persist following the exposure, with the severity of the symptoms becoming pro­gressively worse, resulting in both nausea and vomiting. She also reported an unsuc­cessful attempt to use amplification.
Medical Examination
The patient presented with an essentially normal otolaryngologic examination. Imaging results revealed no retrocochlear involvement.
Impression
Probable unilateral Ménière’s disease.
Audiologic Recommendations and Management
Unilateral amplification was recommended to assist the patient with her significant hearing difficulties. The patient obtained a hearing aid following medical clearance, which was programmed with multiple programs to help manage the fluctuations in her hearing sensitivity. Hearing was monitored following treatment with no
5. Inner Ear Disorders 217
https://t.me/medicina_free
A
Figure 5–6. Pure-tone thresholds, speech audiometry, and tympanometry results for a 27-year-
old female with unilateral Ménière’s disease (Case 5–6) (A) and electrocochleographic recordings from a second individual with Meniere’s disease (B). The latter figure is included to demonstrate the application of EcochG in Ménière’s disease. continues
218 Disorders of the Auditory System
https://t.me/medicina_free
9.02 µV (transtympanic)
3.31 µV
(canal)
.69 µV
05msec
B
(tympanic)
Figure 5–6. continued Transtympanic, tympanic, and ear canal record-
ings are shown from top to bottom (inverting electrode was the ECochG electrode and the noninverting electrode was on the forehead). Note the dif­ferences in amplitude for the three recording sites and the presence of the ABR waves in the canal electrode recording. The amplitude measures reflect mea­surements from the base of the SP to the peak of the AP wave I as shown by dotted arrows. The SP/AP ratio remains about the same for all three record­ings and exceeds 50% in each case.
significant changes in audiologic test results for either pure-tone thresholds or word recognition documented.
Medical Recommendations and Management
The patient underwent a course of pred­nisone and gentamicin treatments and
demonstrated some improvements in vestibular symptoms with this approach. Specifically, a reduction in frequency and severity of vertiginous spells were observed. A low-sodium diet was recom­mended to help control her symptoms. In addition, vestibular rehabilitation to assist with the imbalance was recom­mended.
5. Inner Ear Disorders 219
https://t.me/medicina_free
autoimmune inneR
eaR disease
Introduction
Dysfunction of the immune system can involve the inner ear resulting in fluctu­ating hearing loss with potential tinnitus and vestibular dysfunction. This disease may be caused by antibodies or activated immunologic cells that are directed at the inner ear. An autoimmune inner ear dis­ease (AIED) classification system has been developed and consists of (1) primary disease, which originates within the inner ear, and (2) secondary disease, which is characterized by systemic disease that affects the inner ear (Hughes, Barna, Cal­abrese, & Koo, 1993). Multiple systemic autoimmune diseases have been known to be related to AIED, several of which are Cogan’s syndrome, rheumatoid arthritis, lupus, Hashimoto’s thyroiditis, ulcerative colitis, and Wegener’s granulomatosis (Hughes et al., 1993). Cogan’s syndrome is of particular interest because it mimics Ménière’s disease in its presentation, but it frequently is accompanied by ocular symptoms. A diagnosis of AIED is typi­cally made by exclusion of other diseases that cause similar symptoms.
Symptoms
Autoimmune inner ear disease is char­acterized by bilateral fluctuating sen­sorineural hearing loss. The hearing loss typically occurs over a few months, unlike noise-induced or age-related hear­ing losses, which tend to have a much longer time course. In addition, tinnitus typically accompanies the hearing loss, whereas vertigo or imbalance may or
may not accompany the cycles of hear­ing loss. Although the audiometric con­figuration in AIED may often mimic that of Ménière’s disease, in many patients with AIED, hearing loss is not the pri­mary symptom. In cases with secondary autoimmune disease, such as lupus or Wegener’s granulomatosis, the external and middle ears may also be affected.
Incidence and Prevalence
The incidence of AIED is debated, but likely accounts for less than 1% of all cases of hearing loss. About 50% of patients with AIED have symptoms related to balance (dizziness or unsteadiness) and AIED is more common in patients with other forms of systemic autoimmune dis­ease (Ruckenstein, 2004).
Etiology and Pathology
The dysfunction of the immune system that leads to inner ear disease is complex and has yet to be fully elucidated. T-cell lymphocytes have found to be reactive against inner ear structures (McCabe & McCormick, 1984). Antibodies that are directed at the human inner ear also have been identified (Arnold, Pfaltz, & Alter­matt, 1985). The mechanism by which this autoimmune process occurs, however, is unknown.
Site of Lesion
Relatively little information is available regarding the site at which AIED-induced compromise occurs due to a paucity of temporal bone specimens from patients with active disease processes. It has been
220 Disorders of the Auditory System
https://t.me/medicina_free
assumed to be a cochlear disorder. In one­third of patients, the 68 kilodalton protein has been identified in inner ear extracts, which would implicate the cochlea as the site of action for autoantibodies (Harris & Sharp, 1990).
Audiology
Audiologic evaluation of AIED typically involves a comprehensive audiologic evaluation along with immittance audi­ometry. As these patients often present with fluctuations in hearing sensitivity, serial audiograms are often necessary.
Medical Examination
The diagnosis of AIED is primarily made through careful review of a patient’s his­tory and the exclusion of other common causes of hearing loss. Laboratory test­ing may be normal, especially in times of normal hearing. Specific questions should be asked to rule out other poten­tial diagnoses, such as perilymph fistula, ototoxicity, Ménière’s disease, infectious etiologies, and retrocochlear pathology. A thorough head and neck examination augments the medical history and typi­cally is unremarkable. Other systemic autoimmune disease may cause other otologic manifestations, such as a middle ear effusion in Wegener’s granulomatosis. Care should be taken to document other head and neck manifestations of disease, such as skin rashes or mucosal lesions. Neurotologic examination of vestibular function typically is normal. A panel of serologic blood tests are ordered to exam­ine for markers of systemic inflammation and autoimmune antibodies. If asymme­try in pure-tone audiometry, tuning fork
evaluation, or word recognition testing is identified, then further testing such as ABR or MRI should be performed to rule out retrocochlear pathology.
Audiologic Management
Patients with AIED often present in a man­ner similar to patients with Ménière’s dis­ease. That is, they often have unpredictable fluctuations in their hearing sensitivity. Hearing aids may be utilized for hear­ing loss; however, significant fluctuations make appropriate programming more challenging. In patients who progress to severe or profound hearing loss, cochlear implants can be used successfully.
Medical Management
The mainstay of treatment for this disor­der is systemic steroids, which may have to be titrated to manage acute changes in auditory function. Long-term steroid use is not without complication and typically is not recommended; thus, chemothera­peutic agents, such as cyclophosphamide or methotrexate, are utilized for long-term management. More recently, intratym­panic steroid injections have been utilized in an attempt to achieve the same clinical effect without the systemic side effects.
Case 5–7: Autoimmune Inner Ear Disease
History
This is a 60-year-old female who has been followed for fluctuating hearing loss for 10 years. She was first evaluated for a sud­den sensorineural hearing loss. Through-
5. Inner Ear Disorders 221
https://t.me/medicina_free
out her treatment, she has presented with issues of imbalance and intermittent ver­tigo. Since the onset of her sudden hear­ing loss, she has had significant fluctua­tions in her hearing sensitivity.
Audiology
This patient has undergone many serial audiograms over the years. Audiometric test results both prior to and following treatment are presented in Figures 5–7A and 5–7B. Results obtained upon initial presentation demonstrated a severe sen­sorineural hearing loss and poor word recognition scores bilaterally (see Figure 5–7A). Posttreatment results are discussed in the following sections.
Medical Examination
This patient has undergone extensive medical evaluation by both rheumatology and otolaryngology. Imaging test results ruled out any retrocochlear involvement.
tion, following medical evaluation, treat­ment, and clearance. Following medical intervention and clearance, the patient returned for a hearing aid fitting and was fit with binaural hearing aids that were programmed with multiple programs to assist with her hearing ability when fluc­tuations in hearing occurred. The patient’s hearing continues to be closely monitored due to fluctuations in hearing sensitivity.
Medical Recommendations and Management
The patient was prescribed oral predni­sone and underwent transtympanic dexa­methasone injections. The patient contin­ues to be treated with oral prednisone and dexamethasone as needed to manage the fluctuating hearing loss.
age-Related heaRing
loss (PResBycusis)
Impression
Probable autoimmune inner ear disease.
Audiologic Recommendations and Management
The patient responded well to treatment (see the medical recommendations and management section) and posttreatment audiologic results revealed significant improvements in both hearing sensitivity and word recognition ability with only a mild sensorineural hearing loss and fair to good word recognition scores being observed for both ears (see Figure 5–7B). Given the significant fluctuations noted in hearing sensitivity, it was recommended that the patient obtain binaural amplifica-
Introduction
Age-related hearing loss (ARHL), which also has been referred to as presbycusis, is the decrease of auditory function that occurs with aging. Although the severity ranges greatly, this type of auditory condi­tion involves a decrease in acuity, under­standing, and overall communication and cognitive function. Although nearly all adults experience a decrease in hear­ing sensitivity with time, some individu­als are affected earlier in life and more severely. Unfortunately, the peripheral auditory system has very little reparative capacity, so insults to the auditory sys­tem are additive over time. In addition to changes in the peripheral system, changes in the central auditory system are also